arrow
C

Cristiana Carniti

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:27
被引数:2,412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study

occult 乙型肝炎病毒感染状态与抗CD19 CAR-T细胞疗法治疗淋巴瘤的疗效受损无关,并显示出独特的免疫毒性特征:CART-SIE研究的结果

2026-05-210
OAAI
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life Study

慢性淋巴细胞白血病患者接受维奈克拉治疗期间的可测量残留病灶的纵向监测:一项前瞻性、多中心、真实世界研究的结果

2026-02-100
PRE
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study
2025-11-011
OA
Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma

单核细胞在白细胞分离产品中影响淋巴瘤患者CD19靶向CAR T细胞疗法的结局

2024-01-010
OA
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
LEUKEMIA
IF13.4
2023-01-1818
OAAI
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021-07-2226
OAAI
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
2020-09-1027
OAAI
Timing the initiation of multiple myeloma
2020-04-2198
OAAI
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma
2020-03-0355
OA
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma
2019-03-1917
OAAI
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

多发性骨髓瘤基因组景观分析突出了新的预后标志物和疾病亚组

LEUKEMIA
IF13.4
2018-05-22140
OAAI